(Q53992214)

23 May 2018

title

The absence of stereoselective P-glycoprotein- and multidrug resistance-associated protein-mediated transport of daunorubicin. (English)

1 reference

23 May 2018

main subject

multiple drug resistance

1 reference

1 reference

C Loetchutinat

1

1 reference

23 May 2018

C Heywang

series ordinal

2

1 reference

23 May 2018

W Priebe

series ordinal

3

1 reference

23 May 2018

A Garnier-Suillerot

series ordinal

4

1 reference

23 May 2018

language of work or name

English

0 references

publication date

1 September 2001

1 reference

23 May 2018

published in

Biochemical Pharmacology

1 reference

23 May 2018

volume

62

1 reference

23 May 2018

issue

5

1 reference

23 May 2018

page(s)

561-567

1 reference

23 May 2018

Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900703-1

A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900703-1

Biochemical, cellular, and pharmacological aspects of the multidrug transporter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900703-1

The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900703-1

ABC Transporters: From Microorganisms to Man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900703-1

Correlation between the kinetics of anthracycline uptake and the resistance factor in cancer cells expressing the multidrug resistance protein or the P-glycoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900703-1

Mutually co-operative interactions between modulators of P-glycoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900703-1

Correlation between the short-term measurements of drug accumulation in living cells and the long-term growth inhibition.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900703-1

Kinetics of the multidrug transporter (P-glycoprotein) and its reversal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900703-1

Stereoisomers of calcium antagonists which differ markedly in their potencies as calcium blockers are equally effective in modulating drug transport by P-glycoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900703-1

Comparative effects of racemic verapamil vs R-verapamil on normal and leukemic progenitors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900703-1

Absorption enhancement of hydrophilic compounds by verapamil in Caco-2 cell monolayers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900703-1

The absence of stereoselective P-glycoprotein-mediated transport of R/S-verapamil across the rat jejunum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900703-1

Decreased drug accumulation without increased drug efflux in a novel MRP-overexpressing multidrug-resistant cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900703-1

Non-competitive inhibition of P-glycoprotein-associated efflux of THP-adriamycin by verapamil in living K562 leukemia cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900703-1

Kinetics of daunorubicin transport by P-glycoprotein of intact cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900703-1

Multidrug resistance transporter P-glycoprotein has distinct but interacting binding sites for cytotoxic drugs and reversing agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900703-1

Determination of the osmotic active drug concentration in the cytoplasm of anthracycline-resistant and -sensitive K562 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900703-1

Comparison of the membrane transport of anthracycline derivatives in drug-resistant and drug-sensitive K562 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900703-1

P-glycoprotein-mediated efflux of hydroxyrubicin, a neutral anthracycline derivative, in resistant K562 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900703-1

Kinetics of anthracycline efflux from multidrug resistance protein-expressing cancer cells compared with P-glycoprotein-expressing cancer cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900703-1

Bafilomycins: a class of inhibitors of membrane ATPases from microorganisms, animal cells, and plant cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900703-1

Inhibitory effect of modified bafilomycins and concanamycins on P- and V-type adenosinetriphosphatases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900703-1

Multidrug resistance protein functionality: no effect of intracellular or extracellular pH changes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900703-1

10.1016/S0006-2952(01)00703-1

7 January 2021

Identifiers

DOI

1 reference

23 May 2018

PubMed ID

11585053

1 reference

23 May 2018